Quest Diagnostics Incorporated (DGX)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 16,153,000 16,095,000 13,881,000 13,954,000 14,022,000 13,482,000 13,425,000 12,794,000 12,837,000 13,223,000 13,312,000 13,442,000 13,611,000 13,572,000 12,861,000 13,931,000 14,026,000 14,143,000 12,990,000 12,049,000
Total stockholders’ equity US$ in thousands 6,778,000 6,809,000 6,617,000 6,432,000 6,307,000 6,425,000 6,249,000 6,050,000 5,893,000 6,235,000 6,411,000 6,377,000 6,444,000 6,392,000 5,899,000 6,745,000 6,759,000 6,400,000 5,831,000 5,657,000
Financial leverage ratio 2.38 2.36 2.10 2.17 2.22 2.10 2.15 2.11 2.18 2.12 2.08 2.11 2.11 2.12 2.18 2.07 2.08 2.21 2.23 2.13

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $16,153,000K ÷ $6,778,000K
= 2.38

The financial leverage ratio of Quest Diagnostics Incorporated has been relatively stable over the past few years, ranging between 2.07 and 2.38. This ratio indicates that the company relies on a moderate level of debt financing to support its operations and investments. An increasing trend in the financial leverage ratio may suggest that the company is taking on more debt, which could increase financial risk. On the other hand, a decreasing trend may indicate that the company is paying off its debt or relying more on equity financing. Overall, a financial leverage ratio of around 2.0 to 2.5 is typically considered normal for many companies, indicating a balanced mix of debt and equity in their capital structure.


Peer comparison

Dec 31, 2024